中文名:Remibrutinib (LOU064)
英文名:Remibrutinib (LOU064)
纯度:Moligand™,≥98%
货号:R414448
Cas号:1787294-07-8
存储温度:-20°C储存
运输条件:超低温运输
产品介绍:
Information
Remibrutinib (LOU064) Remibrutinib (LOU064) is a potent, highly selective covalent inhibitor of bruton tyrosine kinase (BTK) with IC50 of 1.3 nM, 2.5 nM and 18 nM for BTK, FcγR-induced IL8 and anti-IgM/IL4-induced CD69, respectively. Remibrutinib (LOU064) exhibits an exquisite kinase selectivity due to binding to an inactive conformation of BTK and has the potential for the treatment of autoimmune diseases.
Targets
BTK (Cell-free assay); IL-8 (Cell-free assay); CD69 (Cell-free assay) 1.3 nM; 2.5 nM; 18 nM
In vitro
LOU064 exhibits an exquisite kinase selectivity due to binding to an inactive conformation of BTK and has the potential for a best-in-class covalent BTK inhibitor for the treatment of autoimmune diseases.
In vivo
LOU064 demonstrates potent in vivo target occupancy with an EC90 of 1.6 mg/kg and dose-dependent efficacy in rat collagen-induced arthritis.
Cell Research(from reference)
Cell lines:human monocytic cell line THP1, Human Blood B cell and Basophil.
Concentrations:3 nM, 10 nM, 30 nM, 100 nM, 300 nM
Incubation Time:25 min, 50 min, 75 min, 100 min
查看阿拉丁官网此产品相关对应页面:https://www.aladdin-e.com/zh_cn/R414448.html



关键字: 瑞布替尼 (LOU064);Remibrutinib (LOU064) ; GTPL10457 ; N-(3-(6-Amino-5-(2-(N-methylacrylamido)ethoxy)pyrimidin-4-yl)-5-fluoro-2-methylphenyl)-4-cyclopropyl-2-fluorobenzamide
上海阿拉丁生化科技股份有限公司是A股上市公司((股票代码:688179),专注于科研试剂的研发、生产和销售,已陆续建立多个工厂和研发中心。作为领军企业,阿拉丁始终坚持质量第一,连续13年被评为“最受欢迎试剂品牌”。
阿拉丁目前常备库存试剂产品品种超过7万种,SKU总数超过46万,产品线涵盖了化学试剂、生化试剂、药靶配体、蛋白质和抗体等多个领域,是国内少数化学试剂到生物试剂全面发展的国产试剂品牌,产品同步发布在我们国内外电商平台。